The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Bayer CEO optimistic about expanding Chinese market
Bill Anderson, CEO of Bayer AG, emphasized China's important role as a strategic pillar for the company's global business operations and shared his commitment to future investment in China in a recent interview with Xinhua.
April22,2024
German agribusiness giant Bayer confident in China's seed industry
German agribusiness giant Bayer is confident in China's seed industry and is willing to participate in China's biotechnology development, as the revitalization drive is accelerating the development of the market, said a Bayer executive.
March22,2024
Bayer loses billions in third quarter, as outlook remains gloomy
German pharmaceutical and agrochemical giant Bayer reported falling sales in the third quarter on Wednesday, continuing a string of poor performances for the struggling firm.
November08,2023
After heavy losses in 2020: Bayer sees annual profit again
After going deeply into the red in 2020, the German agrochemicals and pharmaceuticals group Bayer has returned to profitability. Last year, a consolidated profit of 1 billion euros was achieved, the company announced at its headquarters in Leverkusen on Tuesday.
March04,2022
Monsanto agrees to Bayer deal
Shareholders of US seeds and agrochemicals company Monsanto Co approved the company's $66 billion acquisition by Bayer AG on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017.
December15,2016
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
